Author:
Hsu Chia-Wen,Zhao Jinghua,Xia Menghang
Reference10 articles.
1. Kuipers F, Bloks VW, Groen AK (2014) Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol 10(8):488–498. doi:
10.1038/nrendo.2014.60
2. Merk D, Steinhilber D, Schubert-Zsilavecz M (2012) Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators. Future Med Chem 4(8):1015–1036. doi:
10.4155/fmc.12.47
3. Lamers C, Schubert-Zsilavecz M, Merk D (2014) Medicinal chemistry and pharmacological effects of Farnesoid X Receptor (FXR) antagonists. Curr Top Med Chem 14(19):2188–2205
4. Zheng ZH, Lv GP, Si SY, Dong YS, Zhao BH, Zhang H, He JG (2007) A cell-based high-throughput screening assay for Farnesoid X receptor agonists. Biomed Environ Sci 20(6):465–469
5. Wu X, Glickman JF, Bowen BR, Sills MA (2003) Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists. J Biomol Screen 8(4):381–392. doi:
10.1177/1087057103256466
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献